ASCO Reading Room | A Different Role for ASCT in Multiple Myeloma?
MedPage Today,
Newer, better therapies for multiple myeloma (MM), including immunomodulatory drugs and proteasome inhibitors, have made the…
Newer, better therapies for multiple myeloma (MM), including immunomodulatory drugs and proteasome inhibitors, have made the…
January 24, 2017 Thalidomide plus bortezomib appears to extend median progression-free survival in MM.
January 24, 2017 Thalidomide plus bortezomib appears to extend median progression-free survival in MM.